The DOI matches its Crossref record; 165 of the 165 references it cites were found in a registry or an index.
Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems
Open accessAbstract
BACKGROUND: Prokaryotes have evolved multiple systems to combat invaders such as viruses and plasmids. Examples of such defense systems include receptor masking, restriction-modification (R-M) systems, DNA interference (Argonaute), bacteriophage exclusion (BREX or PGL), and abortive infection, all of which act in an innate, nonspecific manner. In addition, prokaryotes have evolved adaptive, heritable immune systems: clustered regularly interspaced palindromic repeats (CRISPR) and the CRISPR-associated proteins (CRISPR-Cas). Adaptive immunity is conferred by the integration of DNA sequences from an invading element into the CRISPR array (adaptation), which is transcribed into long pre-CRISPR RNAs (pre-crRNAs) and processed into short crRNAs (expression), which guide Cas proteins to specifically degrade the cognate DNA on subsequent exposures (interference). ADVANCES: A plethora of distinct CRISPR-Cas systems are represented in genomes of most archaea and almost half of the bacteria. The latest CRISPR-Cas classification scheme delineates two classes that are each subdivided into three types. Integration of biochemistry and molecular genetics has contributed substantially to revealing many of the unique features of the variant CRISPR-Cas types. Additionally, structural analysis and single-molecule studies have further advanced our understanding of the molecular basis of CRISPR-Cas functionality. Recent progress includes relevant steps in the adaptation stage, when fragments of foreign DNA are processed and incorporated as new spacers into the CRISPR array. In addition, three novel CRISPR-Cas types (IV, V, and VI) have been identified, and in particular, the type V interference complexes have been experimentally characterized. Moreover, the ability to easily program sequence-specific DNA targeting and cleavage by CRISPR-Cas components, as demonstrated for Cas9 and Cpf1, allows for the application of CRISPR-Cas components as highly effective tools for genetic engineering and gene regulation in a wide range of eukaryotes and prokaryotes. The pressing issue of off-target cleavage by the Cas9 nuclease is being actively addressed using structure-guided engineering. OUTLOOK: Although our understanding of the CRISPR-Cas system has increased tremendously over the past few years, much remains to be revealed. The continuing discovery of CRISPR-Cas variants will provide direct tests of the recently proposed modular scenario for the evolution of CRISPR-Cas systems. The recent discovery and characterization of new CRISPR-Cas types with previously unknown features implies that our current knowledge has relatively limited power for predicting the functional details of distantly related CRISPR-Cas variants. Hence, newly discovered CRISPR-Cas systems need to be dissected thoroughly to gain insight into their biological roles, to unravel their molecular mechanisms, and to harness their potential for biotechnology. Key outstanding questions regarding CRISPR-Cas biology include the ecological roles of microbial adaptive immunity, the high rates of CRISPR-Cas horizontal transfer, and the coevolution of CRISPR-Cas and phage-encoded anti-CRISPR proteins. Relatively little is known about the regulation of CRISPR-Cas expression, and about the roles of CRISPR-Cas in processes other than defense. With respect to the CRISPR-Cas mechanism, details illuminating the connection between the adaptation stage and the interference stage in primed spacer acquisition remain elusive. A key aspect of CRISPR-Cas that is poorly understood at present is self/nonself discrimination. The discrimination mechanisms seem to differ substantially among CRISPR variants. Recent comparison of class 2 type effector complexes (Cas9/Cpf1) has revealed overall architectural similarities as well as structural and mechanistic differences, as had previously been found for the distinct types of class 1 effector complexes (Cascade/Cmr). These variations may translate into complementary biotechnological applications. As well as innovative tools for basic research, CRISPR-associated effector complexes will be instrumental for developing the next generation of antiviral prophylactics and therapeutics. For applications in human gene therapy, improved methods for efficient and safe delivery of Cas9/Cpf1 and their guide RNAs to cells and tissues are still needed. Further insight into the basic details of CRISPR-Cas structure, functions, and biology—and characterization of new Cas effector proteins in particular—is crucial for optimizing and further expanding the diverse applications of CRISPR-Cas systems. Evolution of CRISPR-Cas systems resulted in incredible structural and functional diversity.: Class 1 CRISPR-Cas systems are considered to be the evolutionary ancestral systems. The class 2 systems have evolved from class 1 systems via the insertion of transposable elements encoding various nucleases, and are now being used as tools for genome editing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Self-citationRNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D. A., & Horvath, P. (2007) · Science · doi:10.1126/science.1138140 · Cited by 5,947
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
Self-citationGenome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Self-citationRepurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016 · cited 1×
“The dCas9 has been used for transcriptional activation and repression [134-137], for localizing fluorescent protein labels [138], and for recruiting histone modifying enzymes [139, 140].”
MethodCpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
Self-citationCRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696 · cited 1×
“The dCas9 has been used for transcriptional activation and repression [134-137], for localizing fluorescent protein labels [138], and for recruiting histone modifying enzymes [139, 140].”
MethodDouble nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity
Ran, F. A., Hsu, P. D., Lin, C.-Y., Gootenberg, J. S., Konermann, S., Trevino, A. E., Scott, D. A., Inoue, A., Matoba, S., Zhang, Y., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.021 · Cited by 3,299
Self-citationGenetic screens in human cells using the CRISPR-Cas9 system
Wang, T., Wei, J. J., Sabatini, D. M., & Lander, E. S. (2014) · Science · doi:10.1126/science.1246981 · Cited by 2,856
Genome-scale transcriptional activation by an engineered CRISPR-Cas9 complex
Konermann, S., Brigham, M. D., Trevino, A. E., Joung, J., Abudayyeh, O. O., Barcena, C., Hsu, P. D., Habib, N., Gootenberg, J. S., Nishimasu, H., et al. (2015) · Nature · doi:10.1038/nature14136 · Cited by 2,825 · cited 1×
“Other applications of Cas9 include building gene circuits [141-143], creating new anti-microbials [144], antivirals [145-147], and large-scale gain- and loss-of-function screening [148-151] (Table 1).”
BackgroundSelf-citationGasiunas, G., Barrangou, R., Horvath, P., & Siksnys, V. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1208507109 · Cited by 2,769
Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
Gilbert, L. A., Horlbeck, M. A., Adamson, B., Villalta, J. E., Chen, Y., Whitehead, E. H., Guimaraes, C., Panning, B., Ploegh, H. L., Bassik, M. C., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.029 · Cited by 2,728
In vivo genome editing using Staphylococcus aureus Cas9
Ran, F. A., Cong, L., Yan, W. X., Scott, D. A., Gootenberg, J. S., Kriz, A. J., Zetsche, B., Shalem, O., Wu, X., Makarova, K. S., et al. (2015) · Nature · doi:10.1038/nature14299 · Cited by 2,687
Self-citationHigh-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016) · Nature · doi:10.1038/nature16526 · Cited by 2,673
CRISPR RNA Maturation by Trans-Encoded Small RNA and Host Factor RNase III
Deltcheva, E., Chylinski, K., Sharma, C. M., Gonzales, K., Chao, Y., Pirzada, Z. A., Eckert, M. R., Vogel, J., & Charpentier, E. (2011) · Nature · doi:10.1038/nature09886 · Cited by 2,563
An updated evolutionary classification of CRISPR–Cas systems
Makarova, K. S., Wolf, Y. I., Alkhnbashi, O. S., Costa, F., Shah, S. A., Saunders, S. J., Barrangou, R., Brouns, S. J. J., Charpentier, E., Haft, D. H., et al. (2015) · Nature Reviews Microbiology · doi:10.1038/nrmicro3569 · Cited by 2,480
Self-citationSmall CRISPR RNAs Guide Antiviral Defense in Prokaryotes
Brouns, S. J. J., Jore, M. M., Lundgren, M., Westra, E. R., Slijkhuis, R. J. H., Snijders, A. P. L., Dickman, M. J., Makarova, K. S., Koonin, E. V., & van der Oost, J. (2008) · Science · doi:10.1126/science.1159689 · Cited by 2,460
Self-citationRationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414
Self-citationC2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
Abudayyeh, O. O., Gootenberg, J. S., Konermann, S., Joung, J., Slaymaker, I. M., Cox, D. B. T., Shmakov, S., Makarova, K. S., Semenova, E., Minakhin, L., et al. (2016) · Science · doi:10.1126/science.aaf5573 · Cited by 2,336
Self-citationThe CRISPR/Cas bacterial immune system cleaves bacteriophage and plasmid DNA
Garneau, J. E., Dupuis, M.-È., Villion, M., Romero, D. A., Barrangou, R., Boyaval, P., Fremaux, C., Horvath, P., Magadán, A. H., & Moineau, S. (2010) · Nature · doi:10.1038/nature09523 · Cited by 2,328
Crystal structure of Cas9 in complex with guide RNA and target DNA
Nishimasu, H., Ran, F. A., Hsu, P. D., Konermann, S., Shehata, S. I., Dohmae, N., Ishitani, R., Zhang, F., & Nureki, O. (2014) · Cell · doi:10.1016/j.cell.2014.02.001 · Cited by 2,306
RNA-programmed genome editing in human cells
Jinek, M., East, A., Cheng, A., Lin, S., Ma, E., & Doudna, J. (2013) · eLife · doi:10.7554/elife.00471 · Cited by 2,098
Intervening Sequences of Regularly Spaced Prokaryotic Repeats Derive from Foreign Genetic Elements
Mojica, F. J. M., D�ez-Villase�or, C., Garc�a-Mart�nez, J., & Soria, E. (2005) · Journal of Molecular Evolution · doi:10.1007/s00239-004-0046-3 · Cited by 2,042
CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
Platt, R. J., Chen, S., Zhou, Y., Yim, M. J., Swiech, L., Kempton, H. R., Dahlman, J. E., Parnas, O., Eisenhaure, T. M., Jovanovic, M., et al. (2014) · Cell · doi:10.1016/j.cell.2014.09.014 · Cited by 2,001
Self-citationImproving CRISPR-Cas nuclease specificity using truncated guide RNAs
Fu, Y., Sander, J. D., Reyon, D., Cascio, V. M., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2808 · Cited by 1,993
Dynamic Imaging of Genomic Loci in Living Human Cells by an Optimized CRISPR/Cas System
Chen, B., Gilbert, L. A., Cimini, B. A., Schnitzbauer, J., Zhang, W., Li, G.-W., Park, J., Blackburn, E. H., Weissman, J. S., Qi, L. S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.12.001 · Cited by 1,963
Hilton, I. B., D'Ippolito, A. M., Vockley, C. M., Thakore, P. I., Crawford, G. E., Reddy, T. E., & Gersbach, C. A. (2015) · Nature Biotechnology · doi:10.1038/nbt.3199 · Cited by 1,885
Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease
Cho, S. W., Kim, S., Kim, J. M., & Kim, J.-S. (2013) · Nature Biotechnology · doi:10.1038/nbt.2507 · Cited by 1,863
RNA-guided genetic silencing systems in bacteria and archaea
Wiedenheft, B., Sternberg, S. H., & Doudna, J. A. (2012) · Nature · doi:10.1038/nature10886 · Cited by 1,851
DNA interrogation by the CRISPR RNA-guided endonuclease Cas9
Sternberg, S. H., Redding, S., Jinek, M., Greene, E. C., & Doudna, J. A. (2014) · Nature · doi:10.1038/nature13011 · Cited by 1,822
Identification of genes that are associated with DNA repeats in prokaryotes
Jansen, R., Embden, J. D. A. V., Gaastra, W., & Schouls, L. M. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02839.x · Cited by 1,802
CRISPR Interference Limits Horizontal Gene Transfer in Staphylococci by Targeting DNA
Marraffini, L. A., & Sontheimer, E. J. (2008) · Science · doi:10.1126/science.1165771 · Cited by 1,642
Bolotin, A., Quinquis, B., Sorokin, A., & Ehrlich, S. D. (2005) · Microbiology · doi:10.1099/mic.0.28048-0 · Cited by 1,558
Short motif sequences determine the targets of the prokaryotic CRISPR defence system
Mojica, F. J. M., Díez-Villaseñor, C., García-Martínez, J., & Almendros, C. (2009) · Microbiology · doi:10.1099/mic.0.023960-0 · Cited by 1,426
Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease
Anders, C., Niewoehner, O., Duerst, A., & Jinek, M. (2014) · Nature · doi:10.1038/nature13579 · Cited by 1,323
Structures of Cas9 endonucleases reveal RNA-mediated conformational activation
Jinek, M., Jiang, F., Taylor, D. W., Sternberg, S. H., Kaya, E., Ma, E., Anders, C., Hauer, M., Zhou, K., Lin, S., et al. (2014) · Science · doi:10.1126/science.1247997 · Cited by 1,230
Phage Response to CRISPR-Encoded Resistance in Streptococcus thermophilus
Deveau, H., Barrangou, R., Garneau, J. E., Labonté, J., Fremaux, C., Boyaval, P., Romero, D. A., Horvath, P., & Moineau, S. (2008) · Journal of Bacteriology · doi:10.1128/jb.01412-07 · Cited by 1,213
Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems
Shmakov, S., Abudayyeh, O. O., Makarova, K. S., Wolf, Y. I., Gootenberg, J. S., Semenova, E., Minakhin, L., Joung, J., Konermann, S., Severinov, K., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.10.008 · Cited by 1,209
Self-citationPourcel, C., Salvignol, G., & Vergnaud, G. (2005) · Microbiology · doi:10.1099/mic.0.27437-0 · Cited by 1,201
Makarova, K. S., Grishin, N. V., Shabalina, S. A., Wolf, Y. I., & Koonin, E. V. (2006) · Biology Direct · doi:10.1186/1745-6150-1-7 · Cited by 1,199
Self-citationCas9 as a versatile tool for engineering biology
Mali, P., Esvelt, K. M., & Church, G. M. (2013) · Nature Methods · doi:10.1038/nmeth.2649 · Cited by 1,197
Bikard, D., Jiang, W., Samai, P., Hochschild, A., Zhang, F., & Marraffini, L. A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt520 · Cited by 1,145
Self-citationRNA-Guided RNA Cleavage by a CRISPR RNA-Cas Protein Complex
Hale, C. R., Zhao, P., Olson, S., Duff, M. O., Graveley, B. R., Wells, L., Terns, R. M., & Terns, M. P. (2009) · Cell · doi:10.1016/j.cell.2009.07.040 · Cited by 1,031
The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA
Fonfara, I., Richter, H., Bratovič, M., Le Rhun, A., & Charpentier, E. (2016) · Nature · doi:10.1038/nature17945 · Cited by 988
Exploiting CRISPR-Cas nucleases to produce sequence-specific antimicrobials
Bikard, D., Euler, C. W., Jiang, W., Nussenzweig, P. M., Goldberg, G. W., Duportet, X., Fischetti, V. A., & Marraffini, L. A. (2014) · Nature Biotechnology · doi:10.1038/nbt.3043 · Cited by 986
CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea
Marraffini, L. A., & Sontheimer, E. J. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2749 · Cited by 919
Concerning RNA-guided gene drives for the alteration of wild populations
Esvelt, K. M., Smidler, A. L., Catteruccia, F., & Church, G. M. (2014) · eLife · doi:10.7554/elife.03401 · Cited by 856
CRISPR-Cas Systems: Prokaryotes Upgrade to Adaptive Immunity
Barrangou, R., & Marraffini, L. A. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.03.011 · Cited by 832
CRISPR-Cas immunity in prokaryotes
Marraffini, L. A. (2015) · Nature · doi:10.1038/nature15386 · Cited by 829
Optical control of mammalian endogenous transcription and epigenetic states
Konermann, S., Brigham, M. D., Trevino, A. E., Hsu, P. D., Heidenreich, M., Cong, L., Platt, R. J., Scott, D. A., Church, G. M., & Zhang, F. (2013) · Nature · doi:10.1038/nature12466 · Cited by 803
Self-citationCrystal Structure of Cpf1 in Complex with Guide RNA and Target DNA
Yamano, T., Nishimasu, H., Zetsche, B., Hirano, H., Slaymaker, I. M., Li, Y., Fedorova, I., Nakane, T., Makarova, K. S., Koonin, E. V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.003 · Cited by 764
Self-citationGenome-wide analysis reveals specificities of Cpf1 endonucleases in human cells
Kim, D., Kim, J., Hur, J. K., Been, K. W., Yoon, S.-H., & Kim, J.-S. (2016) · Nature Biotechnology · doi:10.1038/nbt.3609 · Cited by 731
Semenova, E., Jore, M. M., Datsenko, K. A., Semenova, A., Westra, E. R., Wanner, B., van der Oost, J., Brouns, S. J. J., & Severinov, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104144108 · Cited by 726
Self-citationUnravelling the structural and mechanistic basis of CRISPR–Cas systems
van der Oost, J., Westra, E. R., Jackson, R. N., & Wiedenheft, B. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3279 · Cited by 714
Self-citationSequence- and Structure-Specific RNA Processing by a CRISPR Endonuclease
Haurwitz, R. E., Jinek, M., Wiedenheft, B., Zhou, K., & Doudna, J. A. (2010) · Science · doi:10.1126/science.1192272 · Cited by 710
A split-Cas9 architecture for inducible genome editing and transcription modulation
Zetsche, B., Volz, S. E., & Zhang, F. (2015) · Nature Biotechnology · doi:10.1038/nbt.3149 · Cited by 710
Self-citationRevenge of the phages: defeating bacterial defences
Samson, J. E., Magadán, A. H., Sabri, M., & Moineau, S. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3096 · Cited by 698
Genome-wide specificities of CRISPR-Cas Cpf1 nucleases in human cells
Kleinstiver, B. P., Tsai, S. Q., Prew, M. S., Nguyen, N. T., Welch, M. M., Lopez, J. M., McCaw, Z. R., Aryee, M. J., & Joung, J. K. (2016) · Nature Biotechnology · doi:10.1038/nbt.3620 · Cited by 670
Functional annotation of native enhancers with a Cas9–histone demethylase fusion
Kearns, N. A., Pham, H., Tabak, B., Genga, R. M., Silverstein, N. J., Garber, M., & Maehr, R. (2015) · Nature Methods · doi:10.1038/nmeth.3325 · Cited by 656
Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli
Yosef, I., Goren, M. G., & Qimron, U. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks216 · Cited by 655
Self versus non-self discrimination during CRISPR RNA-directed immunity
Marraffini, L. A., & Sontheimer, E. J. (2010) · Nature · doi:10.1038/nature08703 · Cited by 637
Conformational control of DNA target cleavage by CRISPR–Cas9
Sternberg, S. H., LaFrance, B., Kaplan, M., & Doudna, J. A. (2015) · Nature · doi:10.1038/nature15544 · Cited by 627
The biology of restriction and anti-restriction
Tock, M. R., & Dryden, D. T. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.06.003 · Cited by 586
Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus
Ebina, H., Misawa, N., Kanemura, Y., & Koyanagi, Y. (2013) · Scientific Reports · doi:10.1038/srep02510 · Cited by 565
Structural basis for CRISPR RNA-guided DNA recognition by Cascade
Jore, M. M., Lundgren, M., van Duijn, E., Bultema, J. B., Westra, E. R., Waghmare, S. P., Wiedenheft, B., Pul, Ü., Wurm, R., Wagner, R., et al. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2019 · Cited by 562
Self-citationMolecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system
Datsenko, K. A., Pougach, K., Tikhonov, A., Wanner, B. L., Severinov, K., & Semenova, E. (2012) · Nature Communications · doi:10.1038/ncomms1937 · Cited by 561
Cas6 is an endoribonuclease that generates guide RNAs for invader defense in prokaryotes
Carte, J., Wang, R., Li, H., Terns, R. M., & Terns, M. P. (2008) · Genes & Development · doi:10.1101/gad.1742908 · Cited by 551
RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection
Hu, W., Kaminski, R., Yang, F., Zhang, Y., Cosentino, L., Li, F., Luo, B., Alvarez-Carbonell, D., Garcia-Mesa, Y., Karn, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405186111 · Cited by 527
CRISPR-based adaptive and heritable immunity in prokaryotes
van der Oost, J., Jore, M. M., Westra, E. R., Lundgren, M., & Brouns, S. J. J. (2009) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.05.002 · Cited by 521
Self-citationBREX is a novel phage resistance system widespread in microbial genomes
Goldfarb, T., Sberro, H., Weinstock, E., Cohen, O., Doron, S., Charpak‐Amikam, Y., Afik, S., Ofir, G., & Sorek, R. (2015) · The EMBO Journal · doi:10.15252/embj.201489455 · Cited by 514
Classification and evolution of type II CRISPR-Cas systems
Chylinski, K., Makarova, K. S., Charpentier, E., & Koonin, E. V. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku241 · Cited by 498
Self-citationDNA-guided DNA interference by a prokaryotic Argonaute
Swarts, D. C., Jore, M. M., Westra, E. R., Zhu, Y., Janssen, J. H., Snijders, A. P., Wang, Y., Patel, D. J., Berenguer, J., Brouns, S. J. J., et al. (2014) · Nature · doi:10.1038/nature12971 · Cited by 493
Self-citationDefense Islands in Bacterial and Archaeal Genomes and Prediction of Novel Defense Systems
Makarova, K. S., Wolf, Y. I., Snir, S., & Koonin, E. V. (2011) · Journal of Bacteriology · doi:10.1128/jb.05535-11 · Cited by 489
Self-citationMakarova, K. S., Aravind, L., Wolf, Y. I., & Koonin, E. V. (2011) · Biology Direct · doi:10.1186/1745-6150-6-38 · Cited by 470
Self-citationCas1–Cas2 complex formation mediates spacer acquisition during CRISPR–Cas adaptive immunity
Nuñez, J. K., Kranzusch, P. J., Noeske, J., Wright, A. V., Davies, C. W., & Doudna, J. A. (2014) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2820 · Cited by 458
Wiedenheft, B., van Duijn, E., Bultema, J. B., Waghmare, S. P., Zhou, K., Barendregt, A., Westphal, W., Heck, A. J. R., Boekema, E. J., Dickman, M. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102716108 · Cited by 449
CRISPR-based adaptive immune systems
Terns, M. P., & Terns, R. M. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.03.005 · Cited by 439
Nissim, L., Perli, S. D., Fridkin, A., Perez-Pinera, P., & Lu, T. K. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.04.022 · Cited by 438
Comparative genomics of defense systems in archaea and bacteria
Makarova, K. S., Wolf, Y. I., & Koonin, E. V. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt157 · Cited by 435
Self-citationCo-transcriptional DNA and RNA Cleavage during Type III CRISPR-Cas Immunity
Samai, P., Pyenson, N., Jiang, W., Goldberg, G. W., Hatoum-Aslan, A., & Marraffini, L. A. (2015) · Cell · doi:10.1016/j.cell.2015.04.027 · Cited by 426
Cas9 specifies functional viral targets during CRISPR–Cas adaptation
Heler, R., Samai, P., Modell, J. W., Weiner, C., Goldberg, G. W., Bikard, D., & Marraffini, L. A. (2015) · Nature · doi:10.1038/nature14245 · Cited by 419
Small molecule–triggered Cas9 protein with improved genome-editing specificity
Davis, K. M., Pattanayak, V., Thompson, D. B., Zuris, J. A., & Liu, D. R. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1793 · Cited by 418
CRISPR–Cas adaptation: insights into the mechanism of action
Amitai, G., & Sorek, R. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2015.14 · Cited by 417
CRISPR adaptation biases explain preference for acquisition of foreign DNA
Levy, A., Goren, M. G., Yosef, I., Auster, O., Manor, M., Amitai, G., Edgar, R., Qimron, U., & Sorek, R. (2015) · Nature · doi:10.1038/nature14302 · Cited by 412
Structures of the RNA-guided surveillance complex from a bacterial immune system
Wiedenheft, B., Lander, G. C., Zhou, K., Jore, M. M., Brouns, S. J. J., van der Oost, J., Doudna, J. A., & Nogales, E. (2011) · Nature · doi:10.1038/nature10402 · Cited by 397
Self-citationA bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity
Seed, K. D., Lazinski, D. W., Calderwood, S. B., & Camilli, A. (2013) · Nature · doi:10.1038/nature11927 · Cited by 386
Self-targeting by CRISPR: gene regulation or autoimmunity?
Stern, A., Keren, L., Wurtzel, O., Amitai, G., & Sorek, R. (2010) · Trends in Genetics · doi:10.1016/j.tig.2010.05.008 · Cited by 384
CRISPR Interference Directs Strand Specific Spacer Acquisition
Swarts, D. C., Mosterd, C., van Passel, M. W. J., & Brouns, S. J. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035888 · Cited by 378
Phage abortive infection in lactococci: variations on a theme
Chopin, M.-C., Chopin, A., & Bidnenko, E. (2005) · Current Opinion in Microbiology · doi:10.1016/j.mib.2005.06.006 · Cited by 366
Multiple mechanisms for CRISPR–Cas inhibition by anti-CRISPR proteins
Bondy-Denomy, J., Garcia, B., Strum, S., Du, M., Rollins, M. F., Hidalgo-Reyes, Y., Wiedenheft, B., Maxwell, K. L., & Davidson, A. R. (2015) · Nature · doi:10.1038/nature15254 · Cited by 356
Integrase-mediated spacer acquisition during CRISPR–Cas adaptive immunity
Nuñez, J. K., Lee, A. S. Y., Engelman, A., & Doudna, J. A. (2015) · Nature · doi:10.1038/nature14237 · Cited by 347
Efficient Intracellular Delivery of Native Proteins
D’Astolfo, D. S., Pagliero, R. J., Pras, A., Karthaus, W. R., Clevers, H., Prasad, V., Lebbink, R. J., Rehmann, H., & Geijsen, N. (2015) · Cell · doi:10.1016/j.cell.2015.03.028 · Cited by 338
CRISPR–Cas systems: beyond adaptive immunity
Westra, E. R., Buckling, A., & Fineran, P. C. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3241 · Cited by 323
CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
Ramanan, V., Shlomai, A., Cox, D. B. T., Schwartz, R. E., Michailidis, E., Bhatta, A., Scott, D. A., Zhang, F., Rice, C. M., & Bhatia, S. N. (2015) · Scientific Reports · doi:10.1038/srep10833 · Cited by 304
Self-citationEfficient CRISPR/Cas9-Mediated Genome Editing in Mice by Zygote Electroporation of Nuclease
Qin, W., Dion, S. L., Kutny, P. M., Zhang, Y., Cheng, A. W., Jillette, N. L., Malhotra, A., Geurts, A. M., Chen, Y.-G., & Wang, H. (2015) · Genetics · doi:10.1534/genetics.115.176594 · Cited by 293
Conditional tolerance of temperate phages via transcription-dependent CRISPR-Cas targeting
Goldberg, G. W., Jiang, W., Bikard, D., & Marraffini, L. A. (2014) · Nature · doi:10.1038/nature13637 · Cited by 293
Structure and Mechanism of the CMR Complex for CRISPR-Mediated Antiviral Immunity
Zhang, J., Rouillon, C., Kerou, M., Reeks, J., Brugger, K., Graham, S., Reimann, J., Cannone, G., Liu, H., Albers, S.-V., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2011.12.013 · Cited by 292
Biogenesis pathways of RNA guides in archaeal and bacterial CRISPR-Cas adaptive immunity
Charpentier, E., Richter, H., van der Oost, J., & White, M. F. (2015) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv023 · Cited by 289
Self-citationCRISPR-Cas and restriction–modification systems are compatible and increase phage resistance
Dupuis, M.-È., Villion, M., Magadán, A. H., & Moineau, S. (2013) · Nature Communications · doi:10.1038/ncomms3087 · Cited by 288
Processing-Independent CRISPR RNAs Limit Natural Transformation in Neisseria meningitidis
Zhang, Y., Heidrich, N., Ampattu, B. J., Gunderson, C. W., Seifert, H. S., Schoen, C., Vogel, J., & Sontheimer, E. J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.001 · Cited by 284
RNA Targeting by the Type III-A CRISPR-Cas Csm Complex of Thermus thermophilus
Staals, R. H. J., Zhu, Y., Taylor, D. W., Kornfeld, J. E., Sharma, K., Barendregt, A., Koehorst, J. J., Vlot, M., Neupane, N., Varossieau, K., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.10.005 · Cited by 282
Self-citationDegenerate target sites mediate rapid primed CRISPR adaptation
Fineran, P. C., Gerritzen, M. J. H., Suárez-Diez, M., Künne, T., Boekhorst, J., van Hijum, S. A. F. T., Staals, R. H. J., & Brouns, S. J. J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400071111 · Cited by 275
Programmable RNA Shredding by the Type III-A CRISPR-Cas System of Streptococcus thermophilus
Tamulaitis, G., Kazlauskiene, M., Manakova, E., Venclovas, Č., Nwokeoji, A. O., Dickman, M. J., Horvath, P., & Siksnys, V. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.027 · Cited by 275
A virocentric perspective on the evolution of life
Koonin, E. V., & Dolja, V. V. (2013) · Current Opinion in Virology · doi:10.1016/j.coviro.2013.06.008 · Cited by 260
Self-citationMemory of viral infections by CRISPR-Cas adaptive immune systems: Acquisition of new information
Fineran, P. C., & Charpentier, E. (2012) · Virology · doi:10.1016/j.virol.2012.10.003 · Cited by 259
Structural and Mechanistic Basis of PAM-Dependent Spacer Acquisition in CRISPR-Cas Systems
Wang, J., Li, J., Zhao, H., Sheng, G., Wang, M., Yin, M., & Wang, Y. (2015) · Cell · doi:10.1016/j.cell.2015.10.008 · Cited by 257
Crystal structure of the CRISPR RNA–guided surveillance complex from Escherichia coli
Jackson, R. N., Golden, S. M., van Erp, P. B. G., Carter, J., Westra, E. R., Brouns, S. J. J., van der Oost, J., Terwilliger, T. C., Read, R. J., & Wiedenheft, B. (2014) · Science · doi:10.1126/science.1256328 · Cited by 247
Self-citationThe Role of CRISPR-Cas Systems in Virulence of Pathogenic Bacteria
Louwen, R., Staals, R. H. J., Endtz, H. P., van Baarlen, P., & van der Oost, J. (2014) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00039-13 · Cited by 247
Self-citationA novel interference mechanism by a type IIIB CRISPR‐Cmr module in Sulfolobus
Deng, L., Garrett, R. A., Shah, S. A., Peng, X., & She, Q. (2013) · Molecular Microbiology · doi:10.1111/mmi.12152 · Cited by 228
Crystal structure of a CRISPR RNA–guided surveillance complex bound to a ssDNA target
Mulepati, S., Héroux, A., & Bailey, S. (2014) · Science · doi:10.1126/science.1256996 · Cited by 225
Liu, Y., Zeng, Y., Liu, L., Zhuang, C., Fu, X., Huang, W., & Cai, Z. (2014) · Nature Communications · doi:10.1038/ncomms6393 · Cited by 223 · cited 1×
“Other applications of Cas9 include building gene circuits [141-143], creating new anti-microbials [144], antivirals [145-147], and large-scale gain- and loss-of-function screening [148-151] (Table 1).”
BackgroundStructure and Activity of the RNA-Targeting Type III-B CRISPR-Cas Complex of Thermus thermophilus
Staals, R. H. J., Agari, Y., Maki-Yonekura, S., Zhu, Y., Taylor, D. W., van Duijn, E., Barendregt, A., Vlot, M., Koehorst, J. J., Sakamoto, K., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.013 · Cited by 218
Self-citationBipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR–Cas system
Elmore, J. R., Sheppard, N. F., Ramia, N., Deighan, T., Li, H., Terns, R. M., & Terns, M. P. (2016) · Genes & Development · doi:10.1101/gad.272153.115 · Cited by 218
Cas9 function and host genome sampling in Type II-A CRISPR–Cas adaptation
Wei, Y., Terns, R. M., & Terns, M. P. (2015) · Genes & Development · doi:10.1101/gad.257550.114 · Cited by 216
Nam, K. H., Haitjema, C., Liu, X., Ding, F., Wang, H., DeLisa, M. P., & Ke, A. (2012) · Structure · doi:10.1016/j.str.2012.06.016 · Cited by 212
Direct CRISPR spacer acquisition from RNA by a natural reverse transcriptase–Cas1 fusion protein
Silas, S., Mohr, G., Sidote, D. J., Markham, L. M., Sanchez-Amat, A., Bhaya, D., Lambowitz, A. M., & Fire, A. Z. (2016) · Science · doi:10.1126/science.aad4234 · Cited by 207
Degradation of Phage Transcripts by CRISPR-Associated RNases Enables Type III CRISPR-Cas Immunity
Jiang, W., Samai, P., & Marraffini, L. A. (2016) · Cell · doi:10.1016/j.cell.2015.12.053 · Cited by 202
Surveillance and Processing of Foreign DNA by the Escherichia coli CRISPR-Cas System
Redding, S., Sternberg, S. H., Marshall, M., Gibb, B., Bhat, P., Guegler, C. K., Wiedenheft, B., Doudna, J. A., & Greene, E. C. (2015) · Cell · doi:10.1016/j.cell.2015.10.003 · Cited by 198
CRISPR transcriptional repression devices and layered circuits in mammalian cells
Kiani, S., Beal, J., Ebrahimkhani, M. R., Huh, J., Hall, R. N., Xie, Z., Li, Y., & Weiss, R. (2014) · Nature Methods · doi:10.1038/nmeth.2969 · Cited by 188
Structure of the CRISPR Interference Complex CSM Reveals Key Similarities with Cascade
Rouillon, C., Zhou, M., Zhang, J., Politis, A., Beilsten-Edmands, V., Cannone, G., Graham, S., Robinson, C. V., Spagnolo, L., & White, M. F. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.08.020 · Cited by 188
Krupovic, M., Makarova, K. S., Forterre, P., Prangishvili, D., & Koonin, E. V. (2014) · BMC Biology · doi:10.1186/1741-7007-12-36 · Cited by 187
Self-citationRichter, C., Dy, R. L., McKenzie, R. E., Watson, B. N. J., Taylor, C., Chang, J. T., McNeil, M. B., Staals, R. H. J., & Fineran, P. C. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku527 · Cited by 183
RNA-activated DNA cleavage by the Type III-B CRISPR–Cas effector complex
Estrella, M. A., Kuo, F.-T., & Bailey, S. (2016) · Genes & Development · doi:10.1101/gad.273722.115 · Cited by 178
Evolution of adaptive immunity from transposable elements combined with innate immune systems
Koonin, E. V., & Krupovic, M. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3859 · Cited by 175
Self-citationThe basic building blocks and evolution of CRISPR–Cas systems
Makarova, K. S., Wolf, Y. I., & Koonin, E. V. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130038 · Cited by 169
Self-citationLi, M., Wang, R., Zhao, D., & Xiang, H. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1154 · Cited by 163
Rutkauskas, M., Sinkunas, T., Songailiene, I., Tikhomirova, M. S., Siksnys, V., & Seidel, R. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.01.067 · Cited by 159
Peng, W., Feng, M., Feng, X., Liang, Y. X., & She, Q. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku1302 · Cited by 151
Crystal Structure of the CRISPR-Cas RNA Silencing Cmr Complex Bound to a Target Analog
Osawa, T., Inanaga, H., Sato, C., & Numata, T. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.03.018 · Cited by 138
Structure of an RNA Silencing Complex of the CRISPR-Cas Immune System
Spilman, M. S., Cocozaki, A. I., Hale, C. R., Shao, Y., Ramia, N. F., Terns, R., Terns, M. P., Li, H., & Stagg, S. M. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.09.008 · Cited by 136
Detection and characterization of spacer integration intermediates in type I-E CRISPR–Cas system
Arslan, Z., Hermanns, V. D.-B., Wurm, R., Wagner, R., & Pul, Ü. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku510 · Cited by 134
MIMIVIRE is a defence system in mimivirus that confers resistance to virophage
Levasseur, A., Bekliz, M., Chabrière, É., Pontarotti, P., Scola, B. L., & Raoult, D. (2016) · Nature · doi:10.1038/nature17146 · Cited by 132
CRISPR interference: a structural perspective
Reeks, J., Naismith, J. H., & White, M. F. (2013) · Biochemical Journal · doi:10.1042/bj20130316 · Cited by 131
Structures of the CRISPR-Cmr complex reveal mode of RNA target positioning
Taylor, D. W., Zhu, Y., Staals, R. H. J., Kornfeld, J. E., Shinkai, A., John van der, O. O. S. T., Nogales, E., & Doudna, J. A. (2015) · Science · doi:10.1126/science.aaa4535 · Cited by 130
Structural basis for the endoribonuclease activity of the type III-A CRISPR-associated protein Csm6
Niewoehner, O., & Jínek, M. (2016) · RNA · doi:10.1261/rna.054098.115 · Cited by 127
Molecular mechanisms of CRISPR-mediated microbial immunity
Gasiūnas, G., Šinkūnas, T., & Šikšnys, V. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1438-6 · Cited by 125
Structural Model of a CRISPR RNA-Silencing Complex Reveals the RNA-Target Cleavage Activity in Cmr4
Benda, C., Ebert, J., Scheltema, R. A., Schiller, H. B., Baumgärtner, M., Bonneau, F., Mann, M., & Conti, E. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.002 · Cited by 125
ISC, a Novel Group of Bacterial and Archaeal DNA Transposons That Encode Cas9 Homologs
Kapitonov, V. V., Makarova, K. S., & Koonin, E. V. (2015) · Journal of Bacteriology · doi:10.1128/jb.00783-15 · Cited by 123
Self-citationDíez‐Villaseñor, C., Guzman, N. M., Almendros, C., García‐Martínez, J., & Mojica, F. J. M. (2013) · RNA Biology · doi:10.4161/rna.24023 · Cited by 122
Hatoum-Aslan, A., Samai, P., Maniv, I., Jiang, W., & Marraffini, L. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.499244 · Cited by 114
Target RNA capture and cleavage by the Cmr type III-B CRISPR–Cas effector complexPreprint
Hale, C. R., Cocozaki, A. I., Li, H., Terns, R. M., & Terns, M. P. (2014) · Genes & Development · doi:10.1101/gad.250712.114 · Cited by 114
Cleavage of Phage DNA by the Streptococcus thermophilus CRISPR3-Cas System
Magadán, A. H., Dupuis, M.-È., Villion, M., & Moineau, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040913 · Cited by 112
CRISPR interference and priming varies with individual spacer sequences
Xue, C., Seetharam, A. S., Musharova, O. S., Severinov, K., Brouns, S. J. J., Severin, A. J., & Sashital, D. G. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1259 · Cited by 106
CRISPR-mediated targeted mRNA degradation in the archaeon Sulfolobus solfataricus
Zebec, Ž., Manica, A., Zhang, J., White, M. F., & Schleper, C. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku161 · Cited by 104
Nature and Intensity of Selection Pressure on CRISPR-Associated Genes
Takeuchi, N., Wolf, Y. I., Makarova, K. S., & Koonin, E. V. (2011) · Journal of Bacteriology · doi:10.1128/jb.06521-11 · Cited by 102
Self-citationCRISPR-Cas systems: new players in gene regulation and bacterial physiology
Sampson, T. R., & Weiss, D. S. (2014) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2014.00037 · Cited by 98
Ivančić-Baće, I., Cass, S., Wearne, S. J., & Bolt, E. L. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1213 · Cited by 98
Artamonova, D., Datsenko, K. A., Medvedeva, S., Bondy‐Denomy, J., Savitskaya, E. E., Pougach, K., Logacheva, M. D., Wiedenheft, B., Davidson, A. R., Severinov, K., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1261 · Cited by 96
Two Distinct DNA Binding Modes Guide Dual Roles of a CRISPR-Cas Protein Complex
Blosser, T. R., Loeff, L., Westra, E. R., Vlot, M., Künne, T., Sobota, M., Dekker, C., Brouns, S. J. J., & Joo, C. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.01.028 · Cited by 92
Rollins, M. F., Schuman, J. T., Paulus, K., Bukhari, H. S. T., & Wiedenheft, B. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv094 · Cited by 92
Evolution of CRISPR RNA recognition and processing by Cas6 endonucleases
Niewoehner, O., Jinek, M., & Doudna, J. A. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt922 · Cited by 88
A Conserved Structural Chassis for Mounting Versatile CRISPR RNA-Guided Immune Responses
Jackson, R. N., & Wiedenheft, B. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.05.023 · Cited by 87
Hooton, S. P. T., & Connerton, I. F. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00744 · Cited by 79
The CRISPR-associated Csx1 protein of Pyrococcus furiosus is an adenosine-specific endoribonuclease
Sheppard, N. F., Glover, C. V. C., Terns, R. M., & Terns, M. P. (2015) · RNA · doi:10.1261/rna.039842.113 · Cited by 76
DNase H Activity of Neisseria meningitidis Cas9
Zhang, Y., Rajan, R., Seifert, H. S., Mondragón, A., & Sontheimer, E. J. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.09.020 · Cited by 75
Inter‐viral conflicts that exploit host CRISPR immune systems of S ulfolobus
Erdmann, S., Bauer, S. L. M., & Garrett, R. A. (2013) · Molecular Microbiology · doi:10.1111/mmi.12503 · Cited by 72
Ramia, N. F., Spilman, M. S., Tang, L., Shao, Y., Elmore, J. R., Hale, C. R., Cocozaki, A. I., Bhattacharya, N., Terns, R. M., Terns, M. P., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.007 · Cited by 61
Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus
Majumdar, S., Zhao, P., Pfister, N. T., Compton, M. M., Olson, S., Glover, C. V. C., Wells, L., Graveley, B. R., Terns, R. M., & Terns, M. P. (2015) · RNA · doi:10.1261/rna.049130.114 · Cited by 54
Koonin, E. V., & Wolf, Y. I. (2014) · Molecular BioSystems · doi:10.1039/c4mb00438h · Cited by 54
Self-citationHickman, A. B., & Dyda, F. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1180 · Cited by 54
CRISPR-Cas Adaptive Immune Systems of the Sulfolobales: Unravelling Their Complexity and Diversity
Garrett, R. A., Shah, S. A., Erdmann, S., Liu, G., Mousaei, M., León‐Sobrino, C., Peng, W., Gudbergsdóttir, S. R., Deng, L., Vestergaard, G., et al. (2015) · Life · doi:10.3390/life5010783 · Cited by 47
Recent Mobility of Casposons, Self-Synthesizing Transposons at the Origin of the CRISPR-Cas Immunity
Krupovìč, M., Shmakov, S., Makarova, K. S., Forterre, P., & Koonin, E. V. (2016) · Genome Biology and Evolution · doi:10.1093/gbe/evw006 · Cited by 41
Self-citationStaphylococcus epidermidis Csm1 is a 3'-5' exonuclease
Ramia, N. F., Tang, L., Cocozaki, A. I., & Li, H. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt914 · Cited by 37
Cited by
Evolutionary classification of CRISPR–Cas systems: a burst of class 2 and derived variants
Makarova, K. S., Wolf, Y. I., Iranzo, J., Shmakov, S. A., Alkhnbashi, O. S., Brouns, S. J. J., Charpentier, E., Cheng, D., Haft, D. H., Horvath, P., et al. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0299-x · Cited by 2,445
Self-citationDiversity, classification and evolution of CRISPR-Cas systems
Koonin, E. V., Makarova, K. S., & Zhang, F. (2017) · Current Opinion in Microbiology · doi:10.1016/j.mib.2017.05.008 · Cited by 1,423
Self-citationThe Biology of CRISPR-Cas: Backward and Forward
Hille, F., Richter, H., Wong, S. P., Bratovič, M., Ressel, S., & Charpentier, E. (2018) · Cell · doi:10.1016/j.cell.2017.11.032 · Cited by 1,039
Diversity and evolution of class 2 CRISPR–Cas systems
Shmakov, S., Smargon, A., Scott, D., Cox, D., Pyzocha, N., Yan, W., Abudayyeh, O. O., Gootenberg, J. S., Makarova, K. S., Wolf, Y. I., et al. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.184 · Cited by 1,029
Self-citationRNA-guided DNA insertion with CRISPR-associated transposases
Strecker, J., Ladha, A., Gardner, Z., Schmid-Burgk, J. L., Makarova, K. S., Koonin, E. V., & Zhang, F. (2019) · Science · doi:10.1126/science.aax9181 · Cited by 708
Self-citation
Metadata
- Authors
- Mohanraju, P., Makarova, K. S., Zetsche, B., Zhang, F., Koonin, E. V., & van der Oost, J.
- Venue
- Science
- Published
- 2016-08-05
- Volume
- 353
- Issue
- 6299
- Pages
- aad5147-aad5147
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2502856725
- Cited by
- 671
- References
- 165
- FWCI
- 39.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.